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ABSTRACT 
Brew B.K, Kull I, Garden F, Almqvist, C, Bergstrom A, Lind T, Webb K, Wickman M, 
Marks G.B. Breastfeeding, Asthma and Allergy: A Tale of Two Cities. 
Pediatr Allergy Immunol 
 
The effect of breastfeeding duration on subsequent asthma and allergy remains the subject of 
much controversy. The objective of this analysis was to investigate whether differences in 
study design or disease-related exposure modification were the cause of the differences in 
study findings. The data from two cohorts, the Childhood Asthma Prevention Study (CAPS) 
from Australia and the Barn Allergi Miljo Stockholm (BAMSE) cohort from Sweden, which 
had reported different findings on the association between breastfeeding and asthma, were 
combined. For this analysis the definitions for breastfeeding, asthma, allergy and were 
harmonized. Subjects were included if they had at least one parent with wheeze or asthma and 
had a gestational age of more than 36 weeks (combined n =882). The risk of disease-related 
exposure modification was assessed using survival analysis.  Breastfeeding reduced the risk of 
asthma at 4/5 and 8 years of age in children with a family history of asthma. The effect was 
stronger in the Swedish cohort. Breastfeeding had no effect on the prevalence of sensitization 
to inhaled allergens in this cohort with a family history of asthma but was a risk factor for 
sensitization to cow’s milk, peanuts and eggs in the CAPS cohort at 4/5 years and in the 
combined cohort at 8 years. There was no evidence to support the existence of disease-related 
exposure modification in either cohort. In conclusion,these findings point to the importance of 
harmonization of features of study design, including subject selection criteria and variable 
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definitions, in resolving epidemiological controversies such as those surrounding the impact 
of breastfeeding on asthma and allergic sensitization. 
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INTRODUCTION 
Asthma is the most common chronic illness that affects  children, with a particularly 
high prevalence in developed countries (1). Simple, inexpensive interventions during early 
childhood, such as promotion of breastfeeding, may have an important role if they are shown 
to be effective in preventing this disease.  
Numerous studies have assessed the effect of breastfeeding on the risk of asthma, 
eczema or allergic sensitisation. During the first few years of life breastfeeding is generally 
considered to be protective for wheeze and asthma (2-4). However, the findings in relation to 
later childhood are varied. Many studies have found no relation between breastfeeding and 
asthma and allergy (5-7), others have found a protective effect (8-11) and still others have 
found breastfeeding to be a risk factor (12-13). It is generally believed by researchers in this 
area that the diversity of results is due to differences in design of the studies. It has also been 
argued that apparent adverse associations may be attributable to a form of bias known as 
reverse causation or disease-related exposure modification (14). Despite improvements in 
study methodology over the last decade there remain important design differences, for 
example; differing definitions for breastfeeding, a lack of consensus for the diagnosis of 
‘asthma’, potential for recall bias due to the assessment of breastfeeding practice several years 
after infancy, and large losses to follow up leading to possible selection bias. In addition, 
there may be other, unrecognized and unmeasured confounders such as environmental factors 
or cultural differences that explain some of the observed heterogeneity. 
The heterogeneity among the existing data is typified by two studies conducted on 
opposite sides of the world, which have recently reported their findings. The Childhood 
Asthma Prevention Study (CAPS) birth cohort was recruited in Sydney, Australia, to include 
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children whose parent/s or sibling had wheeze or asthma prior to the child’s birth. The infants 
were enrolled in a randomized controlled trial testing dietary and house dust mite avoidance 
interventions in the first five years of life. In this cohort, duration of breastfeeding was not 
associated with asthma at age 5 years. However, breastfeeding for 6 months or more was 
associated with an increased prevalence of sensitisation to inhaled and ingested allergens at 
age five years (15). In contrast, the Barn Allergi Miljö Stockholm Epidemiologi (BAMSE) 
general population birth cohort study conducted in Stockholm, Sweden, found a longer 
duration of breastfeeding was protective against the development of asthma and allergen 
sensitization at 4 and 8 years of age (16-17). There are important differences in the selection 
criteria for these study populations and some differences in the definition of exposures or 
outcomes. It is unclear to what extent these divergent findings are attributable to either 
methodological differences or, alternatively, real environmental or lifestyle differences that 
alter the impact of breastfeeding. 
The current study aimed to test the hypothesis that there are not true differences 
between the CAPS and BAMSE populations in the impact of breastfeeding on the risk of 
asthma and allergic sensitization and that the observed differences are explained by selection 
criteria for the cohorts and definitions for exposures and outcomes.  
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METHODS 
Study Design 
This study is an historical cohort study using data from both the BAMSE study in Sweden and 
the CAPS study in Australia.  
CAPS 
CAPS is a randomized, parallel-group controlled trial designed to test the effectiveness of 
interventions to reduce house dust mite levels and to increase omega-3 fatty acid levels by 
supplementation, for the primary prevention of asthma. The results of the randomized 
controlled trial(15) and further details of the study have been published elsewhere (18). In 
brief, pregnant women, whose unborn children were at high risk of having asthma because 
one or more parents or siblings had asthma or wheezing, were identified at the antenatal 
clinics of six Sydney hospitals. Six hundred and sixteen eligible women were enrolled 
between September 1997 and December 1999.  
Data on the age of the child’s mother and father, their educational level, and asthma status, 
and smoking by mother during pregnancy were recorded perinatally. Gestational age, birth 
weight and sex of the child were obtained from hospital records after birth. Smoking by any 
person inside the house was recorded biannually up to 8 years.  
Breastfeeding status was recorded by research nurses visiting the home at 1,3,6,9 and 12 
months. They recorded the age of the child when breastfeeding ceased, the age when breast 
milk substitutes were regularly given and whether the child had been given solids at 3, 6, 9 or 
12 months.  
Asthma outcomes were assessed by questionnaires at 5 yrs and 8 yrs administered to a parent 
or carer by an independent research nurse who was blind to the feeding practices. Skin prick 
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tests (SPT) to inhaled and ingested allergens were performed at 5 yrs (n=395) and 8 yrs 
(n=321), using a method that has been described previously (19). 
The study was approved by the Human Research Ethics Committees of the University of 
Sydney, the Children’s Hospital at Westmead and Western and South Western Sydney Area 
Health Services. 
Of the 616 subjects initially enrolled, ‘ever’ breastfed status could be defined for 601 and 
‘breastfeeding duration’ could be defined for 523. A total of 516 subjects had records for 
breastfeeding and clinical and skin prick test outcomes at 5 yrs and 450 at 8 yrs.  
BAMSE 
BAMSE is a general population birth cohort study which recruited newborns in a predefined 
area of Stockholm between February 1994 and November 1996. In total, 4089 newborn 
infants were included, which comprised 75% of all infants born in that area of Stockholm. 
Further details of the study are described elsewhere (20). 
Data on the age, educational level, and asthma status of the child’s mother and father and 
smoking by mother during pregnancy were recorded when the infants were newborn (median 
age 2 months). Smoking inside the house was recorded at 1, 4 and 8 yrs.  
Duration of any and exclusive breastfeeding as well as age of introduction of solids were 
recorded by questionnaire completed by a parent or carer when the child was aged 12 months.  
Asthma was assessed by questionnaire at 4yrs and 8yrs. Blood was drawn at 4 yrs (n= 2614) 
and 8 yrs (n=2480) and  specific IgE antibody levels to inhalant and ingested allergens were 
measured using the  ImmunoCAP System (Phadia AB, Uppsala, Sweden). 
The study was approved by the Ethics Committee of Karolinska Institutet, Stockholm. 
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Of the 4089 subjects initially enrolled, 3680 (90%) completed the questionnaire at 4 yrs and 
3417 (84%) completed the questionnaire at 8 yrs. For the current study, a subset of the 
population based BAMSE cohort was used according to the selection criteria below.  
Selection criteria 
In order to harmonize the study populations from the two cohorts we chose selection criteria 
for this analysis that could be implemented similarly in both studies. These criteria were : 1) 
one or both parents had current asthma or wheezing prior to child’s birth; 2) no cat at home 
prior to child’s birth (CAPS) or at two months of age (BAMSE); 3) singleton pregnancy; 4) 
gestational age ≥ 36 wks.  
 
Definitions of Exposure Variables and Outcomes  
Common definitions were developed for breastfeeding, asthma and sensitization using the 
data available from both studies.  
Fully breastfed ≥ 3 months. Infants who had not been given a breast-milk substitute or solids 
before 3 months.  
Breastfeeding duration. This is defined as the total duration of ‘any’ breastfeeding, regardless 
of whether solids and breast-milk substitutes had commenced. This duration was classified as: 
< 1 month, ≥ 1 month &< 4 months; ≥ 4 months &<7 months; ≥ 7 months &<10 months; ≥ 10 
months &<13 months; and ≥ 13 months. 
Current Asthma. At ages 4 yrs (BAMSE) or 5 yrs (CAPS) current asthma was defined as 
wheeze in the last 12 months and ever having a doctor or hospital’s diagnosis for asthma OR 
wheeze ≥ 4 times in the last 12months (BAMSE), wheeze for longer than a week ≥ 3 times in 
the last 12 months (CAPS). At 8 yrs of age current asthma was defined as wheeze in the last 
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12 months and ever having a doctor or hospital’s diagnosis for asthma OR wheeze ≥ 4 times 
in the last 12 months (BAMSE and CAPS).  
Sensitization to Ingested Allergens was defined as SPT wheals to egg, milk and peanut 
allergen that were ≥3mm and > negative control at 5 and 8 yrs in CAPS and specific IgE 
antibody titer to the same allergens ≥ 0.35kU/L at 4 and 8 yrs in BAMSE. There is of at least 
fair agreement between these two methods of identifying immediate hypersensitivity to 
inhaled and ingested allergens.(21-22) Sensitization to Local Inhaled Allergens. Because the 
environments of Australia and Sweden are geographically isolated from one another and 
experience different climates, the relevant inhalant allergens in each region are different. In 
Australia, sensitization to inhaled allergens was defined as an allergen weal≥ 3mm and > 
negative control at 5 and 8 yrs to Dermatophagoides pteronyssinus(house dust-mite), 
cockroach, cat, Alternaria, rye or grass mix. In Sweden, sensitization to inhaled allergens was 
defined as IgE antibody levels≥ 0.35kU/L at 4 and 8 yrs to cat, dog, horse, birch, timothy, 
mugwort, Dermatophagoides pteronyssinus, and Cladosporium herbarum. 
 
Statistical Analysis 
All statistical analyses were performed with SAS version 9.1 (SAS, Inc, Chicago, Ill). 
Bivariate associations between breastfeeding and asthma, and sensitization were first 
evaluated using χ2 tests and by computing crude relative risks (RRs) and 95% confidence 
intervals (CI).  
The data from the two cohorts were combined for analysis. We used multiple logistic 
regression with stepwise selection to identify relevant confounders. Potential confounders that 
were tested included maternal asthma, paternal asthma, maternal education, paternal 
education, smoking in pregnancy, second hand smoke (SHS) at 12months, 4/5years or 8years 
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, sex of child, birth weight, maternal age, and gestational age. Adjusted relative risks were 
estimated using log-binomial model that included the main effect and the selected covariates 
that were associated with P values less than 0.1 in the final logistic model. 
The interaction between study (CAPS or BAMSE) and breastfeeding status was also tested 
and if this was significant (p<0.1) the model was fitted separately for CAPS and BAMSE.  
Whether the effect of breastfeeding differed between atopic (those with positive specific IgE 
or skin prick test to one or more allergens) and non-atopic children was tested by including an 
atopy by breastfeeding interaction term in the regression model. Additionally, a three-way 
interaction term was included to test whether this interaction differed between CAPS and 
BAMSE. Stratified analyses were conducted where indicated by significant interactions.  
Survival analysis was used to test where early manifestations of illness may have altered 
breastfeeding practices and hence induced a spurious association between breastfeeding and 
disease, that is, disease-related exposure modification. If there was no relationship between 
onset of allergic symptoms and risk of ceasing breastfeeding this would make reverse 
causation very unlikely as an explanation for any observed association. A Cox proportional 
hazards regression model with a time varying covariate was used for this purpose. (23-24)The 
outcome variable was duration of breastfeeding in months. The time of onset of symptoms 
(wheeze, eczema diagnosis or itchy rash) was modeled as a time varying covariate taking the 
value of 0 if the symptom was not present during the breastfeeding period and taking the 
value of 1 if the symptom was present during the breastfeeding period.  This model was fitted 
separately for the CAPS and BAMSE data and adjusted for socio-economic status.  
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RESULTS 
The study population that met the inclusion criteria and had outcome data available 
consisted of 419 subjects from CAPS at 5 yrs, 362 subjects from CAPS at 8 yrs and 463 
subjects from BAMSE at 4 and 8 yrs.  
Baseline characteristics of the study population, by cohort source, are shown in Table 
1. The subjects in the CAPS study, compared with those in the BAMSE study, were more 
likely to have parents with higher levels of tertiary education; mothers with asthma; and 
exposure to smoking during pregnancy, the first year of life and at 4/5 years.  
Rates of fully breastfeeding ≥ 3 months were much higher in BAMSE (81.2%) than in 
CAPS (33.9%). Similarly, duration of any breastfeeding was longer in Sweden (see Table 1). 
Only 2.2% of infants in BAMSE were breastfed for less than a month compared with 31.3% 
of infants in CAPS. The median breastfeeding duration in BAMSE was 8.8 months, whereas 
in CAPS it was 4.0 months. The decision to fully breastfeed for ≥ 3 months in CAPS was 
associated with higher levels of education for either parent and no SHS exposure during the 
first year of life. In BAMSE full breastfeeding was associated with a higher birth weight and 
no smoking by the mother during pregnancy. 
 
Table 2 shows the prevalence of asthma and sensitization in each subgroup used in 
this study as well as their respective cohorts of origin. At 5 and 8 years the selected subjects 
from the CAPS cohort had higher rates of wheeze, asthma and sensitization to local inhaled 
allergens, whereas the selected BAMSE subjects had significantly higher rates of sensitization 
to ingested allergens. The disease rates in the selected CAPS subjects were similar to those in 
the full CAPS cohort.(15) This was expected as the selected sub-group represented a large 
proportion of the original cohort. In contrast, the subjects selected from the BAMSE cohort 
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had disease rates that were almost double those in the full cohort.(16-17) This is because the 
whole BAMSE cohort had been taken from the general population whereas the subgroup 
selected for this analysis consisted of those who had a parental history of asthma, which is a 
known risk factor for asthma and allergy.  
The effect of fully breastfeeding ≥ 3 months on risk of current asthma at 4/5 years of 
age differed between the CAPS and BAMSE cohorts (p for interaction = 0.06 (see Table 3). 
In CAPS, fully breastfeeding ≥ 3 months made no difference to the asthma outcome at age 5 
years, but in BAMSE fully breastfeeding ≥ 3 months reduced the risk of having asthma at age 
4 years (RR 0.48, 95% CI 0.31 to 0.76). The duration of any breastfeeding and its association 
with asthma at 4/5 years of age did not vary significantly between the two cohorts (p for 
interaction =0.14) and there was no significant relationship found(see Table 4). 
However, the association between fully breastfeeding ≥ 3 months and asthma at age 8 
years did not differ between CAPS and BAMSE cohorts (p for interaction > 0.1). Overall, 
fully breastfeeding ≥ 3 months was associated with a decreased risk of developing asthma 
(RR 0.69, 95% CI 0.52 to 0.93). The effect of any breastfeeding duration on asthma risk at 
age 8 years differed between the two studies (p for interaction = 0.03). Table 4 shows duration 
of any breastfeeding did not have an effect on asthma at age 8 years in CAPS. However, in 
BAMSE every 3 month increase in breastfeeding duration was associated with a reduced risk 
of asthma (RR 0.85 per 3 month period, 95% CI 0.72 to 1.01).  
Full breastfeeding for more than 3 months was associated with an increased risk of 
sensitization to ingested allergens (egg, milk and peanut) in the CAPS study at 4/5 years, but 
not in the BAMSE study (see Table 3). At 8 years the association between full breastfeeding 
and sensitization to ingested allergens did not differ between the cohorts (p for interaction= 
0.59), and the relative risk was 1.81 (95% CI 1.18 to 2.76). Moreover, longer duration of any 
breastfeeding was associated with an increased risk of sensitization to ingested allergens (egg, 
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milk and peanut) at 4/5 and 8 years in the combined data (see Table 4). Tables 3 and 4 show 
that there was no association between breastfeeding duration (any or full) and sensitization to 
local inhaled allergens at 4/5 yrs or at 8 years. 
 Survival analysis (Table 5) found that the presence of early allergic symptoms did not 
influence mothers to breastfeed their children longer than those who did not exhibit these 
symptoms, therefore there is no evidence of reverse causation in these studies. In fact, in this 
subset of the BAMSE cohort, the presence of wheeze while still breastfeeding was associated 
with a 39% increase in the risk of ceasing to fully breastfeed. In other words, in this instance 
early symptoms reduced, rather than increased, the duration of breastfeeding. 
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DISCUSSION 
 
Our results generally support the hypothesis that, after harmonizing selection criteria 
by restricting the population to those with a family history of asthma and using common 
outcome definitions, the effect of breastfeeding on risk of asthma and allergic disease does not 
differ significantly between the Australian CAPS population and the Swedish BAMSE 
population. Overall, our study shows that longer duration of breastfeeding has protective 
effects against asthma and may have adverse effects on the risk of food sensitization. 
However, the findings are complex and some between study centre differences in the 
observed associations were found despite this harmonization of methods. These may be 
attributable to unmeasured confounders such as environmental factors or cultural differences 
between Sweden and Australia.  
The major strength of this current analysis was the use of two birth cohort studies from 
opposite sides of the world with sufficient data in common to allow us to compare and 
contrast their findings. Access to individual patient data from these two cohorts has allowed 
us to undertake a meta-regression using these data, as opposed to the more conventional 
random effects meta-analysis based only on summary measures. The use of individual data 
allowed adjustment for confounding at the level of individual subjects and improved the 
power of the analysis.(25) Although we could apply the same definitions for most of the 
analysis there were some features of the data that could not be harmonized.  
The first is in the definition for asthma at 4/5 years. In both studies we included 
children with ‘ever diagnosed asthma’ and ‘wheeze in the last year’. However, we also 
included subjects without a diagnosis of asthma but with frequent wheeze. In BAMSE this 
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was measured as ‘wheeze more than four times in the last year’ and in CAPS it was measured 
as ‘wheeze for more than 1week more than three times in the last year’. This difference may 
have influenced the findings. However, since most (>80%) of those classified as having 
current asthma in both cohorts were included based on the common component of the 
definition (‘ever diagnosed asthma’ and ‘wheeze in the last year’), it is unlikely this difference 
in selection criteria had a substantial effect.  
The second difference is that CAPS children were assessed at age 5 yrs and BAMSE 
children at 4 yrs. This age difference may be enough to explain the fact that longer duration 
of breastfeeding protected against asthma in BAMSE, but not CAPS at this age. Interestingly, 
at 8 years when the asthma definition and age were the same for both cohorts the study 
groups were found to be similar, full breastfeeding was shown to be protective for asthma. 
This finding is supported by several other studies which measured exclusive breastfeeding for 
3 months and asthma in subjects of similar age (5, 17, 26-27). 
A third difference between the two cohorts is that CAPS was a randomized controlled 
trial and BAMSE was an observational cohort study. It is unlikely that the interventions in 
CAPS will have influenced the findings in this analysis as they did not affect the study 
outcomes (19, 28) and also, as the interventions were randomized, they are unlikely to be 
confounded with breastfeeding status. However, the nature of the trial meant that CAPS 
participants were followed up at frequent intervals throughout the first year of life whereas 
this did not occur in BAMSE. It is possible that this influenced the measurement of 
breastfeeding status.  
The duration of any breastfeeding did not have an effect on asthma prevalence in 
either cohort at either age except in BAMSE at 8 years where every 3 month increase in 
breastfeeding slightly improved the odds of developing asthma.  
  
  Brew 17 
Until recently, recommendations for infant feeding to decrease the risk of allergy 
have promoted exclusive breastfeeding for at least 6 months and avoidance of solids until at 
least 3-6 months (depending on the country).(29) However, recent studies have challenged 
the validity of these recommendations and in some countries they are being re-evaluated. (29) 
For example, some studies have found that increased breastfeeding duration is related to an 
increased sensitization to food allergens in children with a family history of atopy. (30-31) 
We have previously shown in the CAPS cohort that early introduction of solid foods was 
associated with a reduced risk of sensitization. (15) The current analysis supports these 
findings for any breastfeeding and full breastfeeding (except BAMSE at 4 years). 
Some studies have attempted to adjust for reverse causality by excluding infants who 
developed eczema or wheeze before breastfeeding ended or before the age of one year. (16, 
30) The rationale for this restriction is that the mothers of these children may have continued 
to breastfeed these children longer than planned and this would result in a spurious (reverse 
causal) association between breastfeeding duration and asthma. The main problem with this 
method is that if there is a true causal association between longer breastfeeding duration and 
increased risk of symptoms, this will tend to exclude those who manifest this problem. Hence, 
this exclusion method will tend to bias results towards the null whether the apparent 
association is directly causal or reverse causal. The limitation of our study population to those 
with a family history of asthma will have reduced the potential for bias due to reverse 
causation because all subjects have the same family history. Nevertheless, it is possible that 
early manifestations of allergic illness might have led to prolonged breastfeeding and hence 
reverse causation bias. However, the findings of the survival analysis have confirmed that this 
did not, in fact, occur.  
To conclude, longer duration of breastfeeding may protect against asthma in childhood 
but may also be associated with an increased risk of sensitization to foods in children with a 
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family history of asthma. These effects do not seem to be explained by reverse causation. 
Whilst we cannot make a recommendation for or against breastfeeding to reduce the risk of 
allergy-related disorders we can say that applying the same selection criteria and methods to 
combined data sets does harmonize the breastfeeding allergy relationships and needs to be 
attempted using larger sources of data. This will depend on collaboration amongst researchers 
on an international scale. 
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TABLES 
Table 1. Baseline characteristics in selected CAPS and BAMSE subjects#. Values are 
numbers (percentages) unless stated otherwise. 
Variable CAPS  
(n=419) 
BAMSE  
(n=463) 
Male sex 211 (50.4) 240 (51.8) 
Mean Birth Weight (kg) 3.49 3.58 
Mean Gestational age (weeks) 39.6 40.1 
Mean maternal age at delivery (yrs) 28.9 30.0 
Maternal Education: N= 419 N= 459 
 Incomplete Secondary 149 (35.6) 169 (36.8) 
 Complete Secondary 68 (16.2) 97 (21.1) 
 Tertiary 202 (48.2) 193 (42.1) 
Paternal Education: N= 414 N = 445 
  Incomplete Secondary 150 (36.2) 163 (36.7) 
  Complete Secondary 79 (19.1) 120 (27.0) 
 Tertiary 185 (44.7) 162 (36.4) 
Maternal Asthma 287 (68.5) 263 (56.8) 
Paternal Asthma 203 (48.6) 231 (50.3) 
Maternal Smoking during Pregnancy* 104 (24.8) 57 (12.3) 
SHS in first year of life* 124 (29.6) 76/452 (16.8) 
SHS at 4/5 yrs* 109 (26.0) 79/460 (17.2) 
SHS at 8 yrs* 78/398 (19.6) 85/455 (18.7) 
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Breastfeeding:   
Fully Breastfed ≥ 3 months 135/398 (33.9) 367/452 (81.2) 
Duration of Any Breast milk: N=419 N= 452 
 < 1 month 131 (31.3) 10 (2.2) 
  1-3 months 68 (16.2) 32 (7.1) 
 4-6 months 71 (17.0) 79 (17.5) 
 7-9 months 41 (9.8) 150 (33.2) 
 10-12 months 27 (6.4) 114 (25.2) 
 ≥ 13 months 81 (19.3) 67 (14.8) 
# selected for: current maternal and/or paternal asthma or wheeze, >36 weeks gestation, no cat in first 2 months of life,  
singleton pregnancy,* more than one cigarette/day, ^ SPT in CAPS/ IgE in BAMSE  
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Table 2. Asthma and Atopy Outcomes in selected CAPS and BAMSE subjects#and 
whole cohorts. Values are numbers (percentages). 
Variable CAPS# 
 
CAPS 
Whole Cohort 
BAMSE# 
 
BAMSE 
Whole Cohort 
4/5 yrs*: (n=419) (n=516) (n=463) (n=3729) 
  Wheeze in last 12 months 139 (33.2) 165 (32) 109 (23.5) 546 (14.6) 
  Current Asthma 96 (22.9) 109 (21.1) 67/461 (14.5) 285 (7.6) 
Sensitization to Ingested  
Allergens^ 
24/395 (6.1) 25/488 (5.1) 59/348 (17.0) 332/2616 
 (12.7) 
  Sensitization to Local 
Inhaled  Allergens^ 
151/395 (38.2) 179/488 (36.7) 69/348 (19.8) 382/2616 
(14.6) 
8yrs: (n=361) (n=450) (n=463) (n=3417) 
  Wheeze in last 12 months 106 (29.3) 124 (27.6) 91 (19.7) 343 (10) 
  Current Asthma 87 (24.1) 103 (22.9) 63 (13.6) 223 (6.5) 
Sensitization to Ingested  
Allergens^ 
18/331 (5.4) 22/414 (5.3) 80/350 (22.9) 416/2461 
(16.9) 
Sensitization to Local 
Inhaled  Allergens^ 
144/320 (45.0) 178/414 (44.3) 124/350 (35.0) 615//2461 
 (25.0) 
# selected for: current maternal and/or paternal asthma or wheeze, >36 weeks gestation,no cat in first 2 months of life,  
singleton pregnancy,* 4 in BAMSE, 5 in CAPS, ^ SPT in CAPS/ IgE in BAMSE
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Table 3. Effect of Full Breastfeeding for ≥ 3 months on Asthma  at 4/5 yrs and 8 yrs 
  Outcome  n/N (%)  
P value of 
Interaction* 
 
Adjusted RR (95%CI) 
 
 CAPS Crude RR  
(95% CI) 
BAMSE Crude RR  
(95% CI) 
Current Asthma      
4/5yrs#       < 3 months 57/263(21.7) 1.00 20/85 (23.5) 1.00 0.06 1.00 1.00 
                 ≥ 3 months 30/135 (22.2) 1.03 (0.69 to 1.51) 46/367 (12.5) 0.53 (0.33 to 0.85) 1.06 (0.97 to 1.56)a 
CAPS 
0.48 (0.31 to 0.76)b 
BAMSE 
8 yrs        < 3 months 57/224 (25.4) 1.00 18/85 (21.2) 1.00 0.22 1.00 
                 ≥ 3 months  28/118 (23.7) 0.93 (0.63 to 1.38) 48/367 (13.1) 0.62 (0.38 to 1.01)  0.69 (0.52 to 0.93)c 
Sensitization to Ingested Allergens     
4/5 yrs#     < 3 months 10/248 (4.0) 1.00 13/63 (20.6) 1.00 0.02 1.00 1.00 
                 ≥ 3 months 14/127 (11.0) 2.73 (1.25 to 5.98) 44/279 (15.8) 0.76 (0.44 to 1.33)  2.73 (1.25 to 5.99)d 
CAPS 
0.76 (0.44-1.33)d 
BAMSE 
8 yrs        < 3 months 11/206 (5.3) 1.00 15/59 (25.4) 1.00 0.59 1.00 
1.81 (1.18 to 2.76)d                 ≥ 3 months 7/106 (6.6) 1.24 (0.49 to 3.1) 62/283 (21.9) 0.86 (0.53 to 1.41)  
Sensitization to Inhaled Allergens      
4/5 yrs#     < 3 months 87/248 (35.1) 1.00 8/63 (12.7) 1.00 0.19 1.00 
                 ≥ 3 months 55/127 (43.3) 1.23 (0.95 to 1.6) 60/279 (21.5) 1.69 (0.85 to 3.36)  0.9 (0.71 to 1.13)e 
8 yrs        < 3 months 88/199 (44.2) 1.00 19/58 (32.8) 1.00 0.52 1.00 
                ≥ 3 months 47/103 (45.6) 1.03 (0.79 to 1.34) 103/284 (36.3) 1.11 (0.74 to 1.65)  0.89 (0.73 to 1.08)f 
CI: confidence interval; RR: relative risk; *: Study by full BF interaction. If interaction term p  ≤ 0.1,  then countries are analysed separately, if interaction term p  >0.1  then studies are analysed 
together, # age 4 in BAMSE, 5 in CAPS. a= adjusted for birth weight. b= adjusted for maternal age, gender. c= adjusted for gestational age, gender. d= no confounders had a significant effect on 
this relationship. e= adjusted for gender, maternal age, SHS at 5 years, gestational age. f= adjusted for maternal education, gender, smoking during pregnancy. 
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Table 4. The Effect of the Duration of Any Breastfeeding on Outcomes at 4/5 yrs and 8 yrs.  
 
Current Asthma  n/N (%) Sensitization to Ingested Allergens n/N (%) 
Sensitization to Inhaled 
Allergens n/N (%) 
 CAPS          BAMSE CAPS BAMSE CAPS BAMSE 
4/5 yrs# Duration of Breastfeeding     
< 1 month 30/131 (22.9) 1/10 (10) 4/120 (3.3) 2/7 (29) 42/120 (35.0) 1/7 (14.3) 
≥ 1&< 4 months 14/68 (20.6) 11/32 (34.4) 4/66 (6.1) 5/27 (18.5) 18/66 (27.3) 5/27 (18.5) 
≥ 4 &< 7 months 17/71 (23.9) 9/79 (11.4) 3/68 (4.4) 11/55 (20.0) 25/68 (36.8) 7/55 (12.7) 
≥7&< 10 months 9/41 (22.0) 20/150 (13.3) 4/39 (10.3) 15/115 (13.0) 21/39 (53.9) 21/115 (18.3) 
≥10&<13 months 4/27 (14.8) 17/114 (14.9) 1/27 (3.7) 13/88 (14.8) 10/27 (37.0) 21/88 (23.9) 
   ≥ 13 months 22/81 (27.2) 8/67 (11.9) 8/75 (10.7) 11/50 (22.0) 35/75 (46.7) 13/50 (26.0) 
P value of interaction* 0.14 0.26 0.37 
Adj P trend 0.7 0.01 0.58 
RR per Bf duration step  0.97 (0.89-1.05)a 1.19 (1.05 – 1.34)b 1.01 (0.95 – 1.08)c 
8 yrs Duration of Breastfeeding     
< 1 month 24/109 (22.0) 2/10 (20) 5/98 (5.1) 2/6 (33) 43/95 (45.3) 2/6 (33) 
≥ 1&< 4 months 18/62 (29.0) 9/32 (28.1) 4/57 (7.0) 8/24 (33.3) 22/56 (39.3) 7/24 (29.2) 
≥ 4 &< 7 months 14/58 (24.1) 13/79 (16.5) 1/56 (1.8) 12/57 (21.1) 18/52 (34.6) 22/57 (38.6) 
≥ 7&< 10 months 10/32 (31.2) 19/150 (12.7) 1/30 (3.3) 20/117 (17.1) 17/31 (54.8) 36/117 (30.8) 
≥ 10&<13 months 5/27 (18.5) 16/114 (14.0) 2/24 (8.3) 19/87 (21.8) 9/21 (42.9) 33/87 (37.9) 
   ≥ 13 months 20/73 (27.4) 7/67 (10.5) 5/66 (7.6) 16/51 (31.4) 35/65 (53.9) 22/51 (43.1) 
P value of interaction* 0.03 0.7 0.64 
Adj P trend 0.6 0.07 0.03 0.91 
RR per Bf duration step 1.02  (0.95-1.09)d 0.85 (0.72 -1.01)e 1.14 (1.01 – 1.29)f 1.01 (0.95 – 1.07)g 
CI: confidence interval; RR: relative risk; *Study by BF duration interaction. If interaction term p  ≤ 0.1, then countries are analysed separately, if interaction  
term p  >0.1 then studies are analysed together. # age 4 in BAMSE, 5 in CAPS. a = adjusted for gestational age, maternal age, father’s education, gender. b= adjusted for birth 
weight. c= adjusted for gestational age, SHS at 5years, gender. d= adjusted for birth weight, gestational age, gender, maternal and paternal asthma . e= adjusted for maternal 
education, maternal asthma. f= adjusted for father’s education, SHS at 5 years. g= adjusted for smoking during pregnancy, gender.  
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Table 5. Hazard Ratios (HR) for Survival Analysis. 
 
 
Any breastfeeding* Full Breastfeeding* 
 HR 95% CI P-value HR 95% CI P-value 
CAPS       
Itchy Rash 0.85 0.62-1.17 0.31 0.81 0.55-1.18 0.27 
Wheeze 1.13 0.84-1.52 0.41 1.29 0.92-1.80 0.14 
Eczema diagnosis  0.96 0.67-1.39 0.84 0.91 0.51-1.65 0.76 
BAMSE       
Itchy Rash 0.96 0.72-1.27 0.75 0.87 0.60-1.27 0.46 
Wheeze 0.99 0.75-1.31 0.95 1.42 1.01-2.00 0.045 
Eczema diagnosis 0.94 0.71-1.23 0.64 0.88 0.64-1.23 0.46 
Interpretation: If HR is <1 then early sign of symptom is associated with increased risk of prolonged breastfeeding duration.  
If HR>1 then early sign of symptom is associated with an increased risk of breastfeeding cessation.  
*Adjusted for mother’s education and father’s education at the child’s birth.  
 
 
